TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36129996

Group type: EXPERIMENTAL
Intervention: Insulin glargine U-100
Number of subjects: 5047

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 5047

Group type: EXPERIMENTAL
Intervention: Glimepiride
Number of subjects: 5047

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 5047

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 5047
Study: 33906908

Group type: EXPERIMENTAL
Intervention: Apabetalone
Number of subjects: 2425

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2425

Group type: EXPERIMENTAL
Intervention: Non-CKD group
Number of subjects: 2425
Study: 32896014

Group type: EXPERIMENTAL
Intervention: Patient-centred self-administered acupressure intervention
Number of subjects: 30

Group type: COMPARATOR
Intervention: Health education (Control)
Number of subjects: 30
Study: 34453640

Group type: EXPERIMENTAL
Intervention: irinotecan‐alone (irinotecan; 150 mg/m2, day 1, q14 days)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: paclitaxel‐alone (paclitaxel; 80 mg/m2, days 1, 8, 15, q28 days)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: S‐1 plus irinotecan (irinotecan; 80 mg/m2, days 1, 15, S‐1; 80 mg/m2, days 1-21, q35 days)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: S‐1 plus paclitaxel (paclitaxel; 50 mg/m2, day 1, 8, S‐1; 80 mg/m2, days 1-14, q21 days)
Number of subjects: 127
Study: 35257740

Group type: EXPERIMENTAL
Intervention: Nebulized poractant alfa 200 mg/kg
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Nebulized poractant alfa 400 mg/kg
Number of subjects: 129

Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure
Number of subjects: 129
Study: 32366232

Group type: EXPERIMENTAL
Intervention: Palliative care training (4 sessions, 45 min each)
Number of subjects: 40
Study: 35896506

Group type: EXPERIMENTAL
Intervention: AI-based COVID-19 risk score displayed to clinicians
Number of subjects: 1010

Group type: COMPARATOR
Intervention: Control group (no risk score displayed)
Number of subjects: 1010
Study: 34036363

Group type: EXPERIMENTAL
Intervention: Sweetened SQ-LNS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unsweetened SQ-LNS
Number of subjects: 0
Study: 36345917

Group type: EXPERIMENTAL
Intervention: Combination of photobiomodulation therapy (PBMT) and pulsed electromagnetic field therapy (PEMF)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham device (control group)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Combination of PBMT and PEMF
Number of subjects: 80
Study: 33971059

Group type: EXPERIMENTAL
Intervention: mMRC dyspnoea scale
Number of subjects: 10072

Group type: EXPERIMENTAL
Intervention: EuroQol visual analog scale
Number of subjects: 10072

Group type: EXPERIMENTAL
Intervention: Dyspnoea‐12 score
Number of subjects: 10072

Group type: EXPERIMENTAL
Intervention: 4‐item Patient Health Questionnaire (PHQ‐4)
Number of subjects: 10072
Study: 32988520

Group type: EXPERIMENTAL
Intervention: NRS at 13 weeks
Number of subjects: 360

Group type: COMPARATOR
Intervention: FRS at 13 weeks
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: NRS at 8 weeks
Number of subjects: 360
Study: 33583447

Group type: EXPERIMENTAL
Intervention: Standardized advance care planning (ACP) intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Workshop sessions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Theme 2 subthemes
Number of subjects: 0
Study: 34625784

Group type: EXPERIMENTAL
Intervention: Post-induction WT1 MRD level
Number of subjects: 314

Group type: COMPARATOR
Intervention: Allogeneic stem cell transplantation (allo-SCT)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: MRDhigh vs MRDlow
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: MRD response
Number of subjects: 314
Study: 35351779

Group type: EXPERIMENTAL
Intervention: Medication review with shared decision-making (SDM)
Number of subjects: 48
Study: 32554543

Group type: EXPERIMENTAL
Intervention: Level 3 barrier protection personal protective equipment (L3PPE)
Number of subjects: 129
Study: 34856573

Group type: EXPERIMENTAL
Intervention: Anchor-based device
Number of subjects: 47

Group type: COMPARATOR
Intervention: Suture-capturing device
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 47
Study: 34193110

Group type: EXPERIMENTAL
Intervention: Routine care in pediatricians’ practices (intervention group A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Structured interdisciplinary multimodal intervention at social pediatric centers (intervention group B)
Number of subjects: 0
Study: 36100282

Group type: EXPERIMENTAL
Intervention: Adjuvant external beam radiotherapy±brachytherapy ± concomitant chemotherapy
Number of subjects: 514

Group type: COMPARATOR
Intervention: No additional treatment after radical surgery
Number of subjects: 514
Study: 32932273

Group type: EXPERIMENTAL
Intervention: Shave excision
Number of subjects: 45

Group type: COMPARATOR
Intervention: Elliptical excision
Number of subjects: 45
Study: 32319175

Group type: EXPERIMENTAL
Intervention: 10% topical sucralfate ointment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vaseline (placebo)
Number of subjects: 40
Study: 36066979

Group type: EXPERIMENTAL
Intervention: Cartilage conduction hearing device (CCD)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Bone conduction devices (BCDs)
Number of subjects: 16
Study: 33158949

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 3577
Study: 33919799

Group type: EXPERIMENTAL
Intervention: Dental implant coverage limited to one tooth per individual
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Dental implant coverage for front teeth
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Government decision to offer coverage for up to two teeth
Number of subjects: 30
Study: 35538630

Group type: EXPERIMENTAL
Intervention: Nigella sativa oil supplements (2000mg/day)
Number of subjects: 46
Study: 33949055

Group type: EXPERIMENTAL
Intervention: PTFE mesh (ORIHIME™)
Number of subjects: 28

Group type: COMPARATOR
Intervention: PP mesh
Number of subjects: 28
Study: 32711428

Group type: EXPERIMENTAL
Intervention: Health literacy mean score (13.3±3.6)
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Knowledge of Pap smear
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Awareness of cervical cancer
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Awareness of Pap smear
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Attitude towards Pap smear
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Knowledge and attitude towards Cervical Cancer and Pap Smear Questionnaire
Number of subjects: 417
Study: 33988236

Group type: EXPERIMENTAL
Intervention: Oral ferric maltol 30 mg twice daily
Number of subjects: 250

Group type: COMPARATOR
Intervention: Intravenous ferric carboxymaltose
Number of subjects: 250
Study: 33965506

Group type: EXPERIMENTAL
Intervention: Co-infected group at 33°C (T6)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Co-infected group at 28°C (T5)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control group at 23°C (T1)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control group at 28°C (T3)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control group at 33°C (T5)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Co-infected group at 28°C (T4)
Number of subjects: 4
Study: 33031340

Group type: EXPERIMENTAL
Intervention: Bilateral intervertebral foramen block (IFB)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Local infiltration analgesia
Number of subjects: 100
Study: 34889465

Group type: EXPERIMENTAL
Intervention: LGB participants
Number of subjects: 39

Group type: COMPARATOR
Intervention: Heterosexual participants
Number of subjects: 39
Study: 33711179

Group type: EXPERIMENTAL
Intervention: Nemolizumab 30 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35273052

Group type: EXPERIMENTAL
Intervention: MAMS platform trials evaluating medications
Number of subjects: 62

Group type: COMPARATOR
Intervention: MAMS platform trials with repurposed medications as comparison arms
Number of subjects: 62
Study: 34281405

Group type: EXPERIMENTAL
Intervention: Self-Empowered UL Repetitive Engagement (SURE): individualized, UL self-exercise and use outside therapy for 6 hours/week for 4 weeks
Number of subjects: 23

Group type: COMPARATOR
Intervention: Education booklet (Control)
Number of subjects: 23
Study: 32423365

Group type: EXPERIMENTAL
Intervention: CHW-administered screening questions
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: GP-administered screening questions
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: Combination of questions concerning fever, pain, and discolored drainage
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: Overall percent agreement between CHW and health center diagnoses
Number of subjects: 596
Study: 34128426

Group type: EXPERIMENTAL
Intervention: β-glucan (6 g/day)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: inulin (6 g/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 33823295

Group type: EXPERIMENTAL
Intervention: Letter intervention
Number of subjects: 1784

Group type: EXPERIMENTAL
Intervention: Telephone intervention
Number of subjects: 1784

Group type: EXPERIMENTAL
Intervention: Automated telephone intervention
Number of subjects: 1784

Group type: EXPERIMENTAL
Intervention: Automated motivational interviewing (MI) call
Number of subjects: 1784

Group type: EXPERIMENTAL
Intervention: Counselor-delivered MI call
Number of subjects: 1784

Group type: COMPARATOR
Intervention: Survey-only control (Step 1)
Number of subjects: 1784

Group type: COMPARATOR
Intervention: Step 2 control
Number of subjects: 1784

Group type: EXPERIMENTAL
Intervention: Combined stepped interventions
Number of subjects: 1784
Study: 35606137

Group type: EXPERIMENTAL
Intervention: RED-D (Re-Engineered Discharge for Depression) - a 12-week post-discharge telehealth intervention including cognitive behavioral therapy, self-management support, and patient navigation.
Number of subjects: 709

Group type: COMPARATOR
Intervention: RED-only (standard Re-Engineered Discharge without depression treatment)
Number of subjects: 709
Study: 33047372

Group type: EXPERIMENTAL
Intervention: Porcine collagen matrix (CM)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Subepithelial connective tissue graft (SCTG)
Number of subjects: 14
Study: 33749913

Group type: EXPERIMENTAL
Intervention: EPA and DHA, 3.36 g daily
Number of subjects: 31

Group type: COMPARATOR
Intervention: No EPA/DHA (control)
Number of subjects: 31
Study: 33066895

Group type: EXPERIMENTAL
Intervention: Remote Ischemic Post-Conditioning (RIPC)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (Sham Procedure)
Number of subjects: 48
Study: 36354383

Group type: EXPERIMENTAL
Intervention: Degludec U100
Number of subjects: 239

Group type: COMPARATOR
Intervention: Glargine U300
Number of subjects: 239
Study: 33914190

Group type: EXPERIMENTAL
Intervention: Grey matter covariance pattern of double support time variability
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Grey matter covariance pattern of step length variability
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Grey matter covariance pattern of step width variability
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Step time variability
Number of subjects: 351
Study: 32925039

Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (AE)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Dietary Approaches to Stop Hypertension (DASH)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Health Education Control (HE)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Both AE and DASH
Number of subjects: 132
Study: 35026396

Group type: EXPERIMENTAL
Intervention: Inhaled nebulized 30 mg sodium nitrite twice a day for 12 weeks
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 32706859

Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 1130

Group type: COMPARATOR
Intervention: Standard of Care
Number of subjects: 1130
Study: 32366427

Group type: EXPERIMENTAL
Intervention: TissuGlu®
Number of subjects: 70

Group type: COMPARATOR
Intervention: Drain
Number of subjects: 70
Study: 33986493

Group type: COMPARATOR
Intervention: 0 mg caffeine (11 g of decaffeinated coffee)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 200 mg caffeine (5.5 g of caffeinated plus 5.5 g of decaffeinated coffee)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 400 mg caffeine (11 g of caffeinated coffee)
Number of subjects: 25
Study: 32481473

Group type: EXPERIMENTAL
Intervention: RT plus CCSGs
Number of subjects: 40

Group type: COMPARATOR
Intervention: RT
Number of subjects: 40
Study: 36045392

Group type: EXPERIMENTAL
Intervention: Practice change intervention including Brief advice to abstain from alcohol and information about potential risks; referral to phone coaching service for medium-risk and Drug and Alcohol Service for high-risk women.
Number of subjects: 3850

Group type: COMPARATOR
Intervention: Control group (pre-intervention) with no intervention applied.
Number of subjects: 3850
Study: 34466793

Group type: EXPERIMENTAL
Intervention: Emotional Freedom Techniques (EFT) applied for 16 weeks in the immediate treatment group (ITG)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Wait-list control (WLC) group, who started EFT after 8 weeks
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: EFT
Number of subjects: 121
Study: 33393364

Group type: EXPERIMENTAL
Intervention: Individual Cognitive Stimulation Therapy (iCST), 40 sessions over 20 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 40
Study: 32538123

Group type: EXPERIMENTAL
Intervention: Targeted Behavioral Therapy (TBT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 20
Study: 32586932

Group type: EXPERIMENTAL
Intervention: X-82 50mg
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: X-82 100mg
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: X-82 200mg
Number of subjects: 157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: X-82 (all dosages)
Number of subjects: 157
Study: 33352724

Group type: EXPERIMENTAL
Intervention: HFCS-SB (high fructose corn syrup)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Glucose-SB
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Sucrose-SB
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Fructose-SB
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: HFCS-SB
Number of subjects: 131

Group type: COMPARATOR
Intervention: Aspartame-SB
Number of subjects: 131
Study: 36065155

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy
Number of subjects: 320

Group type: COMPARATOR
Intervention: Prior hospitalisation
Number of subjects: 320

Group type: COMPARATOR
Intervention: Employment status
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Stress or anxiety, urges to smoke, lack of motivation
Number of subjects: 320
Study: 34485057

Group type: EXPERIMENTAL
Intervention: Ball endometrial ablation
Number of subjects: 44

Group type: COMPARATOR
Intervention: Transcervical resection of the endometrium (TCRE)
Number of subjects: 44

Group type: COMPARATOR
Intervention: TCRE
Number of subjects: 44
Study: 35534349

Group type: EXPERIMENTAL
Intervention: Synergy drug eluting stent (DES)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Xience drug eluting stent (DES)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Both Synergy and Xience
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Synergy stents
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Xience stents
Number of subjects: 170
Study: 34562202

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 25
Study: 34842579

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 2725
Study: 34582545

Group type: EXPERIMENTAL
Intervention: Low-Carb diet (20% carbohydrate, 21% saturated fat)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Moderate-Carb diet (40% carbohydrate, 14% saturated fat)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: High-Carb diet (60% carbohydrate, 7% saturated fat)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Low-Carb diet
Number of subjects: 164
Study: 33320406

Group type: EXPERIMENTAL
Intervention: Topical minoxidil gel 5%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Topical spironolactone gel 1%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined minoxidil 5% and spironolactone 1% gel
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Histopathological examination
Number of subjects: 60
Study: 33278175

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents
Number of subjects: 1236

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents
Number of subjects: 1236

Group type: COMPARATOR
Intervention: Zotarolimus-eluting stents
Number of subjects: 1236
Study: 32445736

Group type: EXPERIMENTAL
Intervention: Telehealth lifestyle intervention
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual antenatal care
Number of subjects: 200
Study: 32815559

Group type: EXPERIMENTAL
Intervention: FL Evaluation Index (FLEX)
Number of subjects: 1004

Group type: COMPARATOR
Intervention: FLIPI
Number of subjects: 1004

Group type: COMPARATOR
Intervention: FLIPI-2
Number of subjects: 1004

Group type: COMPARATOR
Intervention: PRIMA-Prognostic Index (PRIMA-PI)
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: FL Evaluation Index (FLEX) in SABRINA trial
Number of subjects: 1004
Study: 35597332

Group type: EXPERIMENTAL
Intervention: Protocol-based potassium supplementation (oral potassium chloride to maintain serum potassium of 4-5 mEq/L)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Conventional potassium supplementation (reactive supplementation when serum potassium is <3.5 mEq/L)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Protocol-based potassium supplementation
Number of subjects: 167

Group type: COMPARATOR
Intervention: Conventional potassium supplementation
Number of subjects: 167
Study: 34674862

Group type: EXPERIMENTAL
Intervention: Transcatheter edge-to-edge repair (TEER)
Number of subjects: 372

Group type: COMPARATOR
Intervention: Guideline-directed medical therapy (GDMT)
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Advanced RV-PA uncoupling
Number of subjects: 372
Study: 32817595

Group type: EXPERIMENTAL
Intervention: Cortex Phellodendri Compound Fluid (CPCF)
Number of subjects: 720

Group type: COMPARATOR
Intervention: Kangfuxin solution (KFS)
Number of subjects: 720
Study: 34560665

Group type: EXPERIMENTAL
Intervention: Incremental Cycling Test (INC)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Decremental Cycling Test (DEC)
Number of subjects: 19
Study: 34349568

Group type: EXPERIMENTAL
Intervention: Silicone device (Derma-Stent)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Gauze packing
Number of subjects: 50
Study: 36085879

Group type: EXPERIMENTAL
Intervention: 3kHz stimulation
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 25
Study: 33982408

Group type: EXPERIMENTAL
Intervention: pegvorhyaluronidase alfa (PVHA) plus docetaxel
Number of subjects: 15
Study: 35896988

Group type: EXPERIMENTAL
Intervention: Galcanezumab 120 mg (with 240 mg loading dose)
Number of subjects: 520

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 520
Study: 33401953

Group type: EXPERIMENTAL
Intervention: Statin exposure in anthracycline-treated women
Number of subjects: 1056

Group type: COMPARATOR
Intervention: Unexposed to statins in anthracycline-treated women
Number of subjects: 1056

Group type: EXPERIMENTAL
Intervention: Statin exposure in trastuzumab-treated women
Number of subjects: 1056

Group type: COMPARATOR
Intervention: Unexposed to statins in trastuzumab-treated women
Number of subjects: 1056
Study: 32250171

Group type: EXPERIMENTAL
Intervention: One standard serving (∼11‐15 g) daily of a preferred alcoholic beverage
Number of subjects: 7800

Group type: COMPARATOR
Intervention: Abstention
Number of subjects: 7800
Study: 616119517

Group type: EXPERIMENTAL
Intervention: Diet plus acetazolamide
Number of subjects: 126

Group type: COMPARATOR
Intervention: Diet plus placebo
Number of subjects: 126
Study: 33765687

Group type: EXPERIMENTAL
Intervention: One-week health program of the Social Insurance for Agriculture, Forestry and Horticulture (SVLFG)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Comparison group (no intervention)
Number of subjects: 56
Study: 34794685

Group type: EXPERIMENTAL
Intervention: β-blocker withdrawal (arm A: n = 26)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Continuing β-blocker treatment (arm B: n = 26)
Number of subjects: 52
Study: 35045155

Group type: EXPERIMENTAL
Intervention: Abdominal approach (suture rectopexy)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Abdominal approach (resection rectopexy)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Perineal approach (Delorme's procedure)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Perineal approach (Altemeier's procedure)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Perineal approach
Number of subjects: 134

Group type: COMPARATOR
Intervention: Abdominal approach
Number of subjects: 134
Study: 33048342

Group type: EXPERIMENTAL
Intervention: Remote ischaemic preconditioning (RIPC) - four cycles of 5 minutes forearm ischaemia and reperfusion.
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (standard treatment)
Number of subjects: 38
Study: 35094228

Group type: EXPERIMENTAL
Intervention: EnVista IOL (MX60)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Acrysof IQ IOL (SN60WF)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Both IOLs
Number of subjects: 25
Study: 33760077

Group type: EXPERIMENTAL
Intervention: Decision Support Interventions (DESIs)
Number of subjects: 1339

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 1339
Study: 35119467

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 33798751

Group type: COMPARATOR
Intervention: Intracoronal bleaching treatment with 35 % hydrogen peroxide for 40 min (Control group)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intracoronal bleaching treatment assisted with Er,Cr:YSGG laser (2780 nm) operating at 1.25 W for 30 s
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intracoronal bleaching treatment assisted with Er,Cr:YSGG laser (2780 nm) operating at 2.5 W for 30 s
Number of subjects: 24
Study: 32087600

Group type: EXPERIMENTAL
Intervention: Aquatic Exercise (AE)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Nontreatment Control
Number of subjects: 36